.jpg) |
| Anita Mazloom, M.D., M.S. |
She was previously named chief fellow for two consecutive years.
“I am excited to officially join the USA Health team after completing my fellowship and moving to Mobile,” said Mazloom. “I never lived in the South before coming here for my fellowship, but I love the small-town feel and community aspect. Everyone is welcoming and friendly.”
Mazloom chose to practice at MCI following her three-year fellowship because of its academic medicine capabilities and the work environment.
“I love teaching and also being able to conduct clinical research,” she said. “Part of an academic medical center is leading the next generation of hematologists and oncologists, and I enjoy mentoring residents and fellows. Also, I am excited to open and lead clinical trials at MCI to bring new treatments for our patients.”
Mazloom’s interest in cancer care began prior to medical school when she worked as a research associate for Genentech, a biotechnology company dedicated to discovering and developing medicines for individuals with serious and life-threatening diseases. Mazloom worked with cancer therapeutics and later saw the therapeutics being used clinically during her residency and fellowship programs.
“I am drawn to research and the ability to help patients in an ever-evolving field. Guiding patients through their cancer journey is a rewarding experience as they trust you during a vulnerable time in their lives,” said Mazloom. “Building that bond with patients feels special and I truly cherish it. I have joy in seeing my patients every day and working with a great team at MCI, where everyone has the common goal to help our patients.”
Preceding her oncology and hematology fellowship at USA Health, Mazloom completed her residency at New York-Presbyterian Brooklyn Methodist Hospital/Weill Cornell Medical College in New York. She attended medical school at St. George’s University School of Medicine in Grenada, West Indies.
